CDT earnings date and last-quarter result: P/E -0.10. Updated 2026-07-23.
CDT Equity (CDT) Research Hub
CDT Equity (CDT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.094 USD (-27.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.10, market cap 0.00B. This hub links to the full technical, earnings and options research available for CDT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.094 USD (-27.69%) |
| 52-week range | 0.0684 USD – 19.1 USD |
| Trend regime | Range |
| 14-day RSI | 2.9 (Oversold) |
| Trailing P/E | -0.10 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for CDT
Covered Call on CDT: how it works, illustrative setup around the real 0.094 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CDT: how it works, illustrative setup around the real 0.094 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CDT: how it works, illustrative setup around the real 0.094 USD price, max profit/loss, breakeven and when to use it. Educational.
CDT technical analysis: range, last 0.094 USD, RSI 2.9, 52w range 0.0684 USD–19.1 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CDT in?
CDT Equity (CDT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CDT in an uptrend or downtrend?
As of 2026-10-26, CDT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CDT's trailing P/E ratio?
CDT's trailing P/E is -0.10, with a market cap of 0.00B. See the earnings research page for full valuation detail.